Screening for Residual Disease in Pediatric Burkitt Lymphoma Using Consensus Primer Pools

Assessing molecular persistent or minimal residual disease (PD/MRD) in childhood Burkitt lymphoma (BL) is challenging because access to original tumor is usually needed to design patient-specific primers (PSPs). Because BL is characterized by rearranged immunoglobulin heavy chain (IgV(H)) genes, IgV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Agsalda, Melissa, Kusao, Ian, Troelstrup, David, Shiramizu, Bruce
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2009
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2771857/
https://ncbi.nlm.nih.gov/pubmed/19890467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/412163
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares